Papillary renal cell carcinoma

Papillary renal cell carcinoma
Diagnosis in short
Papillary renal cell carcinoma. H&E stain.
LM	cuboidal or low columnar cells (simple or pseudostratified) on papillae, interstitial foam cells in the vascular cores
Subtypes	type 1, type 2, oncocytic variant
LM DDx	clear cell renal cell carcinoma, clear cell papillary renal cell carcinoma, metanephric adenoma (esp. solid PaRCC type 1), collecting duct carcinoma (esp. PaRCC type 2), renal papillary adenoma, acquired cystic disease-associated renal cell carcinoma, urothelial carcinoma, renal mucinous tubular and spindle cell carcinoma
Gross	may be multifocal, must be >0.5 cm (otherwise renal papillary adenoma), often necrotic-appearing (brown, soft, friable)
Grossing notes	total nephrectomy for tumour grossing, partial nephrectomy grossing
Site	kidney - see kidney tumours
Associated Dx	acquired renal cystic disease (end-stage renal disease)
Syndromes	hereditary papillary renal cell carcinoma, hereditary leiomyomatosis and renal cell cancer
Prevalence	relatively common
Clin. DDx	other kidney tumours
Treatment	surgical excision, ablation

Papillary renal cell carcinoma, abbreviated PRCC, PaRCC and papillary RCC, is the second most common type of renal cell carcinoma.

General

• Often subclassified into type 1 and type 2 -- see microscopic.
  • Type 1 and Type 2 are different on a cytogenetic and molecular basis.

Epidemiology

• Associated with acquired renal cystic disease.
• May be familial - uncommon.
  • MET mutation - autosomal dominant transmission, PaRCC type 1.

Gross

• Renal cortical mass > 0.5 cm.
• May be multifocal. ‡
• Often necrotic appearing - light-to-dark brown, soft/mushy, friable.

Note:

• ‡ Approximately 10% of PaRCCs are multifocal (based on a set of 5378 patients); it is the renal tumour that is most commonly multifocal.

Microscopic

Features:

• Cuboidal or low columnar cell in papillae.
• Interstitial foam cells in vascular cores - key feature.
  • Most sensitive and specific feature of PaRCC.
• Highly vascular.

Size criterion:

• Papillary lesions must be >0.5 cm to be called carcinoma; smaller lesions (<=0.5 cm) are called papillary adenomas.

Mnemonic HIP: highly vascular, interstitial foam cells, papillae.

DDx:

• Clear cell RCC.
  • Papillary: histiocytes, intracellular hemosiderin, CK7 +ve.
• Clear cell papillary renal cell carcinoma - apical nuclei, usu. no true papillae.
• Metanephric adenoma (esp. solid PaRCC type 1) - no histiocytes, WT-1 +ve.
• Collecting duct carcinoma - esp. PaRCC type 2.
• Urothelial carcinoma.
• Renal papillary adenoma - doesn't fulfill size criterion for PaRCC.
• Acquired cystic disease-associated renal cell carcinoma.
• Renal mucinous tubular and spindle cell carcinoma.
• Hereditary leiomyomatosis and renal cell carcinoma - for type 2 PaRCC; CK7 -ve, prominent eosinophilic nucleoli.

Images

• 

  PaRCC - intermed. mag. (WC/Nephron)

• 

  PaRCC - high mag. (WC/Nephron)

• 

  PaRCC - very high mag. (WC/Nephron)

• 

  PaRCC - intermed. mag. (WC)

• 

  PaRCC - high mag. (WC)

• 

  PaRCC - very high mag. (WC)

• 

  PaRCC - high mag. (WC/Nephron)

• 

  PaRCC - very high mag. (WC/Nephron)

Histological subtyping

Generally accepted subtypes:

• Type 1 - single layer of cells on basement membrane - most important.
  • Usually low grade nuclear features, i.e. low Fuhrman grade.
  • Other characteristics:
    • Clear cytoplasm.
    • Foamy macrophages - common.
    • Cells smaller.
• Type 2 - pseudostratification of cells - most important.
  • Usually high grade nuclear features, i.e. high Fuhrman grade.
  • Other characteristics:
    • Eosinophilic cytoplasm.
    • Foamy macrophages - uncommon.
    • Cells larger.

Another subtype:

• Oncocytic - oncocytic cytoplasm.
  • Extremely rare ~ largest series is 12 cases.

IHC

Features:

• AMACR +ve.
• HMWCK (34betaE12) +ve.
• Panker (AE1/AE3) +ve.
• CK7 +ve ~90% of type 1, 20% of type 2.
• CD10 +ve.

More reading:

• PaRCC (e-immunohistochemistry.info).

Type 1 versus Type 2:

• CK7:
  • Type 1 ~ 100%.
  • Type 2 ~ 19%.
• CK19:
  • Type 1 ~ 100%.
  • Type 2 ~ 53%.

Metanephric adenoma vs. PaRCC type 1:

• AMACR +ve.
• WT-1 -ve.
• CD57 -ve.

Molecular

Features:

• Sporadic: trisomies 7, 16, 17.
• Familial: trisomy 7.
  • Chromosome 7 = location of MET gene.

Note:

• Not used for diagnosis.

Sign out

KIDNEY, RIGHT, RADICAL NEPHRECTOMY:
- PAPILLARY RENAL CELL CARCINOMA, TYPE 1, FUHRMANN GRADE 3, pT2a(2), pNx.
-- SURGICAL MARGINS NEGATIVE.
-- PLEASE SEE TUMOUR SUMMARY.
- RENAL PAPILLARY ADENOMAS.

Micro

The sections show a tumour in the kidney with fibrovascular cores (papillae) that focally contain macrophages. Psammoma bodies are present. Siderophages are present.

The papillae predominantly have a single layer of tumour cells and the cytoplasm of the tumour cells is predominantly clear.

Nucleoli are visible focally with the 10x objective (ISUP nucleolar grade 3).

A second tumour with the same morphology is present and measures 8 millimetres.

Multiple small lesions, like the largest tumour, less than 0.5 cm are present.

Oncocytic variant

KIDNEY, RIGHT, NEPHRECTOMY:
- PAPILLARY RENAL CELL CARCINOMA, ONCOCYTIC -- SEE COMMENT;
- FUHRMANN GRADE 2;
- SURGICAL MARGINS NEGATIVE;
- PLEASE SEE TUMOUR SUMMARY.

COMMENT:
The oncocytic variant of papillary renal cell carcinoma (RCC) is uncommon and not widely
recognized as a subtype of papillary RCC.  The prognostic significance of the oncocytic 
cytoplasm is uncertain.[1]  The histomorphology in this case is compatible with a type 1 
papillary RCC.

1. Ann Diagn Pathol. 2006 Jun;10(3):133-9.

See also

• Kidney tumours.
• Acquired cystic disease-associated renal cell carcinoma.